Department of Pathology
  Brigham and Women's Hospital
  A teaching Affliate of Harvard Medical School
Login Skip Navigation Links
  Skip Navigation Links
HomeExpand Home


Submit new announcement
Milenko Tanasijevic, M.D.,M.B.A.

Associate Professor of Pathology, Harvard Medical School

Academic Activities:

75 Francis Street
AL-2-215 Amory building
Boston,MA 02115
Education and Training:

Medical School - : University Cyril and Methodius Medical School, Macedonia M.D.
Internship 12/1987 - 12/1988 : University Cyril and Methodius Medical School
Residency 2/1990 - 2/1993 : Brigham and Women's Hospital
Graduate School 5/2004 - : Boston University MBA

Clinical Specialties:
  • Clinical Chemistry
Research Interests:
  • Marker identification
  • Atherosclerosis
  • Bioinformatics
  1. Tanasijevic MJ, Cannon C. Evaluation of Coronary Artery Patency Using Cardiac Markers. In press: Journal of Thrombosis and Thrombolysis 2005; 19:21-24
  2. McElrath TF, Colon I, Hecht J, Tanasijevic MJ, Norwitz ER. Neonatal respiratory distress syndrome as a function of gestational age and an assay for surfactant-to-albumin ratio. OB GYN 2004; 103(3):463-8.
  3. Sabatine M, Morrow DA, deLemos JA, Omland T, Desani MY, Tanasijevic MJ, Hall C, McCabe CH, Braunwald E. Acute Changes in Circulating Natriuretic Peptide Levels in Relation to Myocardial Ischemia. JACC 2004; 44(10):1988-1995.
  4. Srinivas VS, Cannon CP, Gibson M, Antman EM, Greenberg MA, Tanasijevic MJ, Murphy S, de Lemos JA, Sokol S, Braunwald E and Miller HS. Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality following thrombolysis in acute myocardial infarction: a TIMI 10B substudy. American Heart Journal 2001; 142:29-36.
  5. de Lemos JA, Morrow DA, Gibson CM, Murphy SA, Rifai N, Tanasijevic M, Giugliano RP, Schuhwerk KC, McCabe CH, Cannon CP, Antman EM and Braunwald E, for the TIMI 14 Investigators. Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy. Am J Cardio 2001; 88:353-358.
  6. Morrow DA, Rifai N, Tanasijevic MJ, Wybenga DR, De Lemos JA, Antman E. Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: A thrombolysis in myocardial infarction (TIMI) 11B Substudy. Clin Chem 2000; 46(4):453-460.
  7. Morrow DA, Antman EM, Tanasijevic M, Rifai N, deLemos JA, McCabe CH, Cannon CP, Braunwald E. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: A TIMI 11B substudy. JACC 2000; 36:1812-7.
  8. Delgado JC, Green MF, Winkelman JW, Tanasijevic MJ. Comparison of disaturated phosphatidylcholine and FLM S/A ratio in diabetic and nondiabetic pregnancies. Am J Clin Path 2000; 113:233-239.
  9. Tanasijevic MJ, Cannon CP, Antman EM, Wybenga DR, Fischer GA, Grudzien C, Gibson CM, Winkelman JW, Braunwald E. Myoglobin, creatin-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction. Results from the thrombolysis in myocardial infarction study TIMI 10B. J Am Coll Cardio 1999; 34:739-747.
  10. Tanasijevic MJ, Cannon CP, Wybenga D, Fischer G, Grudzien C, McCabe CH, Gibson M, Fischer G, Wybenga D, Antman EM, Braunwald E. Cardiac troponin I, myoglobin and CK-MB for non-invasive assessment of reperfusion after thrombolytic therapy for acute myocardial infarction. Am Heart J 1997; 134:622-630.
<June 2019>

<Monday, June 24, 2019>
8:00 AM

Cotran Conference Center
8:00 AM

Autopsy suite
9:00 AM

Clinical Lab conference room
3:00 PM

Dammin signout suite
Copyright 2008 - 2019, BWH Pathology, All rights reserved.